Pulmonary Circulation


Publication Venue For

  • BREEZE: Open-label clinical study to evaluate the safety and tolerability of treprostinil inhalation powder as Tyvaso DPI™ in patients with pulmonary arterial hypertension.  12. 2022
  • Delphi consensus recommendation for optimization of pulmonary hypertension therapy focusing on switching from a phosphodiesterase 5 inhibitor to riociguat.  12. 2022
  • An expert panel Delphi consensus statement on the use of palliative care in the management of patients with pulmonary arterial hypertension.  12. 2022
  • Implantable system for treprostinil and lung transplantation: case series from delivery for pulmonary arterial hypertension study.  11. 2021
  • Implantable system for treprostinil: a real-world patient experience study.  10. 2020
  • Impact of patient characteristics and perceived barriers on referral to exercise rehabilitation among patients with pulmonary hypertension in the United States.  10. 2020
  • Long-term results of the DelIVery for Pulmonary Arterial Hypertension trial.  9. 2019
  • Barriers to physical activity in patients with pulmonary hypertension.  9. 2019
  • Recommendations for the clinical management of patients receiving macitentan for pulmonary arterial hypertension (PAH): A Delphi consensus document.  7:702-711. 2017
  • Novel methods in pulmonary hypertension phenotyping in the age of precision medicine (2015 grover conference series).  6:439-447. 2016
  • An observational study of inhaled-treprostinil respiratory-related safety in patients with pulmonary arterial hypertension.  6:329-337. 2016
  • Physician attitudes toward palliative care for patients with pulmonary arterial hypertension: Results of a cross-sectional survey.  4:504-510. 2014
  • Erythropoietin upregulation in pulmonary arterial hypertension.  4:269-279. 2014
  • A unique pulmonary microvascular endothelial cell niche revealed by weibel-palade bodies and Griffonia simplicifolia.  4:111-115. 2014
  • The serine-threonine phosphatase calcineurin is a regulator of endothelial store-operated calcium entry.  4:116-127. 2014
  • Reproducibility of intracardiac and transpulmonary biomarkers in the evaluation of pulmonary hypertension.  3:345-349. 2013
  • International Standard Serial Number (issn)

  • 2045-8932
  • 2045-8940
  • Electronic International Standard Serial Number (eissn)

  • 2045-8940